Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,273 total articles

Adamas Trust Declares Second Quarter 2026 Common Stock Dividend of $0.27 Per Share, and Preferred Stock Dividends

Adamas Trust Declares Second Quarter 2026 Common Stock Dividend of $0.27 Per Share, and Preferred Stock Dividends

Adamas Trust, Inc., a REIT focused on real estate and capital markets investments, declared a quarterly common stock dividend of $0.27 per share for Q2 2026, payable July 28, 2026. Additionally, cash dividends were declared for various series of preferred stocks with payments due July 15, 2026. The company reiterated forward-looking statements abou…

Genco Shipping & Trading Limited Board of Directors Provides Firm Commitments for Future Treatment of Shareholders Rights Agreement

Genco Shipping & Trading Limited Board of Directors Provides Firm Commitments for Future Treatment of Shareholders Rights Agreement

Genco Shipping & Trading Limited's Board of Directors reaffirms its commitment to protect shareholder interests by maintaining its Shareholder Rights Agreement to prevent a hostile takeover by Diana Shipping Inc. The Board encourages shareholders to vote in favor of continuing the Rights Agreement and reelect its current directors while rejecting D…

Ingredion Names Kenneth Escoe to Board of Directors

Ingredion Names Kenneth Escoe to Board of Directors

Ingredion Incorporated, a global ingredient solutions provider, has appointed Kenneth Escoe to its board of directors effective July 1. Escoe brings extensive leadership experience across capital-intensive businesses, focusing on operations, commercial strategy, and M&A, which is expected to support Ingredion's long-term growth.

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Insight Molecular Diagnostics announced publication in the American Journal of Transplantation demonstrating the superior diagnostic performance of its GraftAssure Combination Model (CM)-score assay for detecting kidney transplant rejection. The CM-score, integrating relative and absolute donor-derived cell-free DNA measurements, shows increased po…

Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026

Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026

Seneca Foods Corporation reported increased net sales and improved gross margins for the fiscal year ended March 31, 2026, achieving record full-year FIFO diluted EPS of $14.15. The company also completed the acquisition of the U.S. Green Giant Frozen business, expanding its frozen product segment and market footprint. Quarterly results also showed…

Eos Energy Announces Record Date for Rights Offering

Eos Energy Announces Record Date for Rights Offering

Eos Energy Enterprises, a US-based innovator in zinc-based long-duration energy storage, announced the record date for a rights offering aimed at raising funds to support its capital contribution to the Frontier Power USA joint venture. Eligible holders of common stock and warrants will receive subscription rights to purchase units at a discount, i…

Mohawk Industries Announces CEO Succession Plan

Mohawk Industries Announces CEO Succession Plan

Mohawk Industries announced that Paul F. De Cock will become CEO on September 30, 2026, succeeding Jeff Lorberbaum, who is retiring after leading the company for 25 years and will remain Chairman. De Cock brings extensive industry experience and has been instrumental in expanding Mohawk's global operations and product portfolio. The leadership tran…

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Elutia Inc. announced that its CEO and CSO will present at the Planet MicroCap Showcase 2026, focusing on their drug-eluting biomatrix technology designed to mitigate post-surgical infection in implant-based breast reconstruction following mastectomy. The company highlights the potential to improve patient outcomes by reducing complications and rev…

Treace to Present at the Sidoti Small Cap Conference

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc., a Nasdaq-listed medical device company specializing in innovative surgical solutions for bunions and midfoot deformities, announced it will present at the Sidoti Small Cap Conference on June 18, 2026. The company is known for its patented Lapiplasty 3D Bunion Correction System and other surgical technologies designed …

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines, a clinical-stage biopharmaceutical company developing novel medicines targeting historically undruggable proteins, closed its upsized initial public offering on Nasdaq under ticker PBLS at $20 per share. The IPO raised gross proceeds of $770.5 million, including full exercise of underwriters' over-allotment option. Additionally…

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio announced new data from the Phase 3 MATTERHORN trial showing the drug roxadustat significantly improves transfusion independence in patients with anemia due to lower-risk myelodysplastic syndromes (LR-MDS), regardless of ring sideroblast (RS) status. The company is finalizing the protocol for a pivotal Phase 3 trial based on FDA feedback…

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW, a leading game platform company specializing in anime IP-based free-to-play web games, announced that CFO Patrick Liu will participate and present at the Planet MicroCap Las Vegas 2026 investment conference from June 16-18. The presentation and one-on-one meetings aim to engage investors and showcase CTW's business and growth strategies.

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox Imaging Ltd announces it will release its first quarter 2026 financial results on June 25, 2026, followed by a conference call hosted by CEO Erez Meltzer and CFO Ran Daniel. The company provides an update on its integrated medical imaging platform aimed at expanding preventive healthcare through affordable imaging technology, AI analytics, cl…

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

Ascendis Pharma announced positive five-year Phase 2 data from the PaTH Forward Trial demonstrating that TransCon PTH (palopegteriparatide) provides sustained multi-organ benefits, normalizes calcium levels, improves kidney function and quality of life, and allows independence from conventional therapies in adults with hypoparathyroidism. High pati…